In this episode, we explore the vital role of Medicaid Fraud Control Units (Mufukus) in combating healthcare fraud across the United States. Our guests, Candace Deisher and Sarah Vann, share insights into how these specialized units operate, their impact, and the importance of whistleblowers and data analysis in uncovering fraud.

In this episode, we explore the FinCEN whistleblower program, its recent regulatory updates, and how it aims to incentivize reporting of financial crimes like money laundering and sanctions evasion. Experts Poppy Alexander and Andrew Feller share insights on the program's structure, protections, and areas for improvement.

This episode explores the complex landscape of SLAPP suits against whistleblowers, including strategies for protection, legal defenses, and the evolving legal protections. Experts Clay Weier and Grace Park share insights on how whistleblowers can navigate and defend against retaliatory lawsuits.

This episode explores the enforcement landscape of financial fraud in 2025, highlighting trends, the role of whistleblowers, and future priorities across agencies like the SEC, CFTC, IRS, and international counterparts. Gain insights into how whistleblower programs are shaping enforcement and what to expect in the coming years.

In this episode, investigative journalist Gardner Harris discusses his book 'No More Tears,' which exposes the dark secrets of Johnson & Johnson. He reveals the company's history of fraud, including the baby powder scandal, the deadly EPO drug, and the antipsychotic Risperdal. Harris emphasizes the role of whistleblowers in uncovering these truths and calls for significant reforms in drug regulation to prevent future tragedies.

In the third installment of our AI series, we turn to one of the most consequential—and fast-moving—frontiers in enforcement: how the SEC is regulating artificial intelligence. We sit down with Daren Firestone to break down the schemes increasingly drawing regulatory scrutiny, including “AI washing,” recent SEC settlements involved investment advisers that made false and misleading claims about their use of artificial intelligence, and the growing use of AI tools in cyber-enabled misconduct like hacking and ransomware. We explore how these developments are reshaping the SEC’s enforcement priorities, what companies need to know as AI becomes more deeply integrated into financial services, and what all of this means for potential whistleblowers navigating an evolving landscape. Daren Firestone is a Partner at Levy Firestone Muse. Learn more about Daren: https://www.levyfirestone.com/team/daren-firestone/

In the second installment of our three-part AI series, we dive into one of the most rapidly evolving areas of law and policy: the regulation of artificial intelligence. We sit down with Sophie Luskin and Claire Sylvia to explore how federal and state governments are approaching AI regulation, what the proposed AI Whistleblower Protection Act could mean for those who raise concerns, and what retaliation protections exist for whistleblowers in this emerging space. We also discuss how AI is beginning to interact with the False Claims Act—both as a tool for detecting fraud and as a technology that may help whistleblowers bring new cases. Sophie Luskin is a Senior Tech Policy Analyst with Kohn, Kohn, & Colapinto LLP and Claire Sylvia is a Partner at Phillips & Cohen LLP.

Artificial intelligence is transforming nearly every sector of the economy, but its rapid expansion has also created confusion, compliance gaps, and new areas of risk. From cybersecurity concerns to evolving standards and government guidance, organizations are struggling to understand both the promise and the pitfalls of these powerful tools. In today’s episode, we sit down with Dave Jochnowitz and Rachel Rose to break down what AI actually is in clear, accessible terms, why governments and industry groups are racing to regulate it. We explore how AI is already being deployed in legal and compliance work, where it helps, where it falls short, and the professional responsibilities attorneys must navigate when using it.

Medicare Advantage has grown to insure over half of all Medicare beneficiaries, but with that explosive growth has come an explosion in fraud. Billions of dollars in taxpayer money are being siphoned off through schemes that exploit the program's risk-adjustment payment system—from upcoding patient diagnoses to fabricating medical conditions entirely.

This month, The Department of Justice's Antitrust Division announced a brand new Whistleblower Rewards Program, marking a significant step forward in empowering whistleblowers to expose antitrust crimes operating in secrecy. In today's episode, we sit down with two whistleblower attorneys, David Kovel and Poppy Alexander to discuss the new program, potential pitfalls, and opportunities for whistleblowers to take advantage of this new program. Poppy Alexander is a Partner at Whistleblower Partners and David Kovel is Managing Partner at Kirby McInerney.